The Aarhus researchers discovered that a mutation in the SORL1 gene, which affects the SORLA protein, leads to a reduction in the production of exosomes in brain cells by about 30%. Exosomes are small vesicles that provide communication between cells and promote the growth and maturation of surrounding cells. Exosomes produced by cells with mutant SORLA were up to 50% less effective in promoting the health of neighboring neurons and microglia. This defect in exosome production and quality disrupts intercellular communication, which may contribute to the development of Alzheimer's disease. The mutation also alters the microRNA content of exosomes, reducing their neurotrophic properties. Research suggests that restoring or enhancing exosome function could be a new therapeutic strategy in the treatment of Alzheimer's disease. This discovery represents an important step in understanding the mechanisms that lead to brain damage in Alzheimer's disease.